Procurement of proprietary Chinese medicines/biological preparations in a gradual and orderly manner, and companies focus on five aspects!

editor

The No.
2 document of the State Council puts forward the requirements of "exhaustive extraction" and "three-level operation".
The author believes that within 1 to 2 years, the centralized and volumetric procurement of the pharmaceutical field will definitely be carried out intensively
.
The document also emphasizes that in accordance with the requirements of government organizations, alliance procurement, and platform operations, promote the construction of regional and national alliance procurement mechanisms; the medical security department will guide or organize relevant regions and medical institutions to form a centralized drug procurement alliance to strengthen work coordination.
, To deploy and implement key tasks; centralized drug procurement agencies in the alliance region jointly established a cross-regional joint procurement office to implement centralized drug procurement on behalf of medical institutions in the alliance region, and organize and supervise the implementation of procurement results
.
It can be inferred from this that in the future, inter-provincial alliances will become the direction of policy requirements, and centralized procurement methods and methods will be more abundant, as will the centralized procurement of Chinese patent medicines and biological agents .
  Facing the centralized procurement pilot projects in various regions, pharmaceutical companies need to pay attention to the following aspects:   First, the product evaluation rules in various regions.
From the perspective of the projects that have been carried out, the proportion of the comprehensive evaluation method is relatively high, which is different from the past.
New changes in the past two years, but the evaluation elements and weights set in each project are quite different .
Second, there are big differences in quality stratification and grouping in different regions .
The third is that the calculation methods of the agreed procurement volume of each project are different.
For example, the proportion of the procurement volume of medical institutions in the previous year was 30%, 50%, 60%, 70%, and 80%, which are very different .
Fourth, the number of selected products in each project varies greatly .
Fifth, the requirements and restrictions on the unselected products are also very different .